77 results
8-K
EX-99.1
SAVA
Cassava Sciences Inc
1 May 24
Other Events
9:13am
, Texas. Our mission is to detect and treat neurodegenerative diseases, such as Alzheimer’s disease.
For more information, please visit: https
8-K
EX-99.1
SAVA
Cassava Sciences Inc
15 Apr 24
Redemption Date Announced for Warrants
4:01pm
mission is to detect and treat neurodegenerative diseases, such as Alzheimer’s disease. Our novel science is based on stabilizing—but not removing
8-K
EX-99.1
SAVA
Cassava Sciences Inc
28 Feb 24
Cassava Sciences Reports Full-year 2023 Financial Results and Corporate Updates
9:22am
.
Cassava Sciences is a clinical-stage biotechnology company based in Austin, Texas. Our mission is to detect and treat neurodegenerative diseases
8-K
EX-99.1
SAVA
Cassava Sciences Inc
7 Feb 24
No Decline in Cognition Scores in Patients with Mild Alzheimer's Disease Who Received Simufilam Continuously For 24 Months
9:20am
is a clinical-stage biotechnology company based in Austin, Texas. Our mission is to detect and treat neurodegenerative diseases, such as Alzheimer’s
424B2
c0tpf7w6vhkip
3 Jan 24
Prospectus for primary offering
4:22pm
8-K
EX-99.1
eovzg0mqwrf
12 Dec 23
Cassava Sciences Announces Dividend Distribution of Warrants to Shareholders
9:19am
8-K
EX-99.1
w2plm2sgu00174i6juv1
11 Dec 23
Cassava Sciences Appoints
4:18pm
8-K
EX-99.1
8pbod
7 Nov 23
Cassava Sciences Reports Third Quarter 2023 Financial and Operating Results
9:08am
8-K
EX-99.1
sngmlj0eovvmh 5p
3 Aug 23
Cassava Sciences Reports Q2 2023 Financial Results and Operating Updates
9:12am
8-K
EX-99.1
o9umrf0a ypy
5 Jul 23
Other Events
9:25am
424B5
cdru7d5lfii0ahcn1xor
1 May 23
Prospectus supplement for primary offering
5:26pm
S-3ASR
7sq2zze9equs6
1 May 23
Automatic shelf registration
4:01pm
8-K
EX-99.1
g7i mkt7nf9v
1 May 23
Cassava Sciences Reports Q1 2023 Financial Results and Operating Updates
9:05am
8-K
EX-99.1
d7zmj zp7f
22 Nov 22
Cassava Sciences Announces $50 Million Registered Direct Offering of Common Stock
12:49pm
8-K
EX-99.2
xn2fvdpqi 1t0el
22 Nov 22
Cassava Sciences Announces $50 Million Registered Direct Offering of Common Stock
12:49pm
424B5
ol59j7xkr rx7w6
21 Nov 22
Prospectus supplement for primary offering
8:00am